Primary obesity surgery endoluminal (POSE-2) procedure for treatment of obesity in clinical practice.
Gontrand Lopez NavaRavishankar AsokkumarJanese LasterAnuradha NegiEnrique NormandStephanie Fook-ChongInmaculada Bautista-CastañoPublished in: Endoscopy (2020)
POSE-2 induced significant weight loss at 1 year. It appears to be safe, durable, and required only a short hospital stay.
Keyphrases
- weight loss
- bariatric surgery
- minimally invasive
- clinical practice
- insulin resistance
- roux en y gastric bypass
- metabolic syndrome
- gastric bypass
- weight gain
- high fat diet induced
- type diabetes
- healthcare
- coronary artery bypass
- high glucose
- diabetic rats
- glycemic control
- adipose tissue
- drug induced
- emergency department
- atrial fibrillation
- adverse drug
- percutaneous coronary intervention
- endothelial cells
- smoking cessation